OverviewChartTechnicalNewsTraderScreen

ADC Therapeutics SA/  CH0499880968  /

NYSE
2024-05-10  10:10:00 PM Chg. -0.27 Volume Bid2:00:00 AM Ask2:00:00 AM High Low
4.30USD -5.91% 1.17 mill.
Turnover: 4.53 mill.		 4.00Bid Size: 2,100 4.85Ask Size: 1,000 4.58 4.03
GlobeNewswire 05-09 ADC Therapeutics to Participate in 2024 RBC Capital Markets Global Healthcare Conference
GlobeNewswire 05-06 ADC Therapeutics Announces $105 Million Underwritten Offering of Common Shares and Pre-Funded Warran...
GlobeNewswire 05-06 BioNTech Announces First Quarter 2024 Financial Results and Corporate Update
GlobeNewswire 05-06 ADC Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Updates
GlobeNewswire 05-06 ADC Therapeutics Announces Initial Data from Investigator-Initiated Phase 2 Clinical Trial of ZYNLON...
GlobeNewswire 05-01 ADC Therapeutics Makes Grants to New Employees Under Inducement Plan
GlobeNewswire 05-01 ADC Therapeutics to Host First Quarter 2024 Financial Results and Pipeline Update Conference Call on...
GlobeNewswire 04-22 BioNTech to Report First Quarter 2024 Financial Results and Corporate Update on May 6, 2024
GlobeNewswire 04-07 Three-year Phase 1 Follow-Up Data for mRNA-based Individualized Immunotherapy Candidate Show Persis...
GlobeNewswire 04-04 ADC Therapeutics Announces Updates on LOTIS-7 Clinical Trial Evaluating ZYNLONTA® in Combination wit...
GlobeNewswire 04-03 ADC Therapeutics to Host a Virtual Research Investor Event on Tuesday, April 9, 2024
GlobeNewswire 04-01 ADC Therapeutics Makes Grants to New Employees Under Inducement Plan
GlobeNewswire 03-20 BioNTech Announces Fourth Quarter and Full Year 2023 Financial Results and Corporate Update
GlobeNewswire 03-20 BioNTech Announces Appointment of Annemarie Hanekamp to Management Board as Chief Commercial Officer
GlobeNewswire 03-13 ADC Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business U...
GlobeNewswire 03-11 BioNTech to Present Clinical Data Updates for Personalized mRNA-based and Targeted Oncology Candidat...
GlobeNewswire 03-07 BioNTech Announces Planned Retirement of Sean Marett
GlobeNewswire 03-06 ADC Therapeutics to Participate in the Guggenheim 5th Annual Healthy Altitudes Summit
GlobeNewswire 03-06 ADC Therapeutics to Host Fourth Quarter and Year-End 2023 Financial Results Conference Call on March...
GlobeNewswire 03-05 ADC Therapeutics Announces Abstracts Accepted for Presentation at the American Association for Cance...
GlobeNewswire 02-16 Smart Immune appoints key new members to its Board of Directors
GlobeNewswire 02-08 BioNTech and Autolus Announce Strategic CAR-T Cell Therapy Collaboration to Advance Pipeline and Exp...
GlobeNewswire 02-08 BioNTech and Autolus Announce Strategic CAR-T Cell Therapy Collaboration to Advance Pipeline and Exp...
GlobeNewswire 01-31 BioNTech and DualityBio Receive FDA Fast Track Designation for Next-Generation Antibody-Drug Conjuga...
GlobeNewswire 01-22 BioNTech and DualityBio Initiate Pivotal Phase 3 Trial Of Antibody-Drug Conjugate Candidate BNT323/...